sipatrigine and riluzole
sipatrigine has been researched along with riluzole in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Berlove, D; Burke-Howie, K; Durant, GJ; Fan, W; Fischer, JB; Magar, SS; Perlman, ME; Reddy, NL; Wolcott, T; Yost, E; Zhang, L | 1 |
Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Obrenovitch, TP | 1 |
Bernardi, G; Caputi, L; Hainsworth, AH; Lavaroni, F; Martella, G; Mercuri, NB; Spadoni, F; Stefani, A | 1 |
Reviews
3 review(s) available for sipatrigine and riluzole
Article | Year |
---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
Sodium and potassium channel modulators: their role in neuroprotection.
Topics: Animals; Benzeneacetamides; Cell Survival; Disease Models, Animal; Lamotrigine; Neurons; Neuroprotective Agents; Piperazines; Piperidines; Potassium Channels; Pyrimidines; Riluzole; Sodium Channels; Thiazoles; Triazines | 1997 |
Other Studies
2 other study(ies) available for sipatrigine and riluzole
Article | Year |
---|---|
Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Cell Line; CHO Cells; Cricetinae; Drug Design; Guanidine; Guanidines; Mice; Mice, Inbred DBA; Molecular Structure; Piperazines; Pyrimidines; Riluzole; Seizures; Sodium Channel Blockers; Structure-Activity Relationship; Veratridine | 1998 |
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Cerebral Cortex; Dose-Response Relationship, Drug; Epilepsy; Lamotrigine; Male; Membrane Potentials; Neural Inhibition; Neuroprotective Agents; Piperazines; Pyramidal Cells; Pyrimidines; Rats; Rats, Wistar; Riluzole; Sodium; Sodium Channel Blockers; Sodium Channels; Triazines | 2002 |